MCET Employee's all found separately on LinkedIn website.
1) Lucille Gomes-Avelar Administrative Manager at MultiCell Technologies, Inc. MultiCell Technologies, Inc. Providence County, Rhode Island, United States100 connections
Experience Administrative Manager MultiCell Technologies, Inc. Nov 1999 - Present21 yrs 3 mos
Barbara Corbett Investor Relations at MultiCell Technologies, Inc.
Connect mariano vicente perez ejecutivo de ventas en MultiCell Technologies, Inc.
Connect Grant Miller, MBA/CFO Chief Financial & Operating Officer, Encore Semi LLC
2) mariano vicente perez ejecutivo de ventas en MultiCell Technologies, Inc. unachMultiCell Technologies, Inc. Tuxtla Gutiérrez, Chiapas, Mexico3 connections
Experience ejecutivo de ventas MultiCell Technologies, Inc. Aug 2005 - Present15 yrs 6 mos Ventas de telefonía celular
Education unach licenciatura en pedagogia 2012 - 2014 Activities and societies: Equipo de fútbol, danza, exposición, conferencias cbta tecnico en agronegocios 2001 - 2004 Activities and societies: Equipo de fútbol
10) Grant Miller, MBA/CFO Chief Financial & Operating Officer, Encore Semi LLC University of San DiegoEncore Semi, LLC Coronado, California, United States500+ connections
Experience Chief Financial & Operating Officer Encore Semi, LLC Oct 2012 - Present8 yrs 4 mos
Encore Semi provides senior engineering services and technology solutions to the worlds Top Tier Chip makers such as Qualcomm, Toshiba, Samsung, IBM, and more.
Provide operations and financial leadership for an entreprenureal tech company experiencing explosive growth with Quarter over Quarter growth for 12 consecutive quarters. From start up to $15 ~ $20M run rate in 3 years.
Lead all infrastructure implementation to support growth in headcount projected at more than 100 by End of 2014.
Responsible for Finance, Legal, Sales, Recruiting, Hardware and Software Engineering Services, HR, and IT. Board of Directors MultiCell Technologies, Inc. Oct 2012 - Present8 yrs 4 mos
Board member for a public Biotech company; Board Chairman of the Audit Committee.
11) Dário Pereira sócio proprietário na Multicell. PolivalenteMultiCell Technologies, Inc. Altamira, Pará, Brazil42 connections
Experience sócio proprietário MultiCell Technologies, Inc. sócio proprietário Multicell.
12) Simona Bot, MD Blue Heron Foundation 9 yrs 3 mos
Vice President Jan 2018 - Present 3 yrs 1 mo
Beverly Hills, California Improving the quality of life of Romania's orphaned and abandoned children and providing them with greater access to life's opportunities. Mentor Nov 2011 - Present 9 yrs 3 mos
Improving the quality of life of Romania's orphaned and abandoned children and providing them with greater access to life's opportunities. Consulting Scientist Biopharmaceutical Industry 2003 - Present 18 yrs 2 mos
Consulting Scientist MultiCell Technologies, Inc. 2011 - Oct 2019 8 yrs 11 mos
Evaluating new drug candidates in human hepatocellular carcinoma models.
13)
Stephen Chang Dr. Chang has been a director at Histogen since 2007, and he served as Histogen’s Interim Chief Executive Officer from April 2017 to January 2019. In addition to Histogen, Dr. Stephen Chang serves on the Scientific Advisory Board or Board of Directors for GT Biopharma, Orphesus Therapeutics, Cloak Therapeutics, Aegis Therapeutics and Legacy Therapeutics. He also serves as Director of Research for One Med Research, a life science communications and analysis firm in NYC. and is an entrepreneur in residence at Rutgers and New York University.
Dr. Chang recently retired from the New York Stem Cell Foundation (NYSCF). As Senior Vice President for Strategic Initiatives and Research, Dr. Chang had overall responsibility for planning, coordinating, and managing the activities of the research department. In this role, he provided senior leadership in the areas of research and development, oversight of short and long term projects with regulations and policies related to administration and business units, partnerships with industry and other research institutions, and supervision and evaluation of internal and external projects and intellectual property.
Prior to joining NYSCF, Dr. Chang founded Stemgent, Inc. in 2008 and served as the Company’s Chief Scientific Officer. He was previously the CEO of Multicell Technologies and continues as a Director of this Company. He has been involved in Viagene, Chiron and Canji/Schering Plough in the area of gene and cancer therapy.
Chang recently retired from the New York Stem Cell Foundation (NYSCF). As Senior Vice President for Strategic Initiatives and Research
Market Data 
Markets 
AI
